Pacific Biosciences Of California | PACB - Current Assets

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $394.24M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Bruker USD 2.21B 138.1M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Pacific Biosciences Of California USD 394.24M 19.16M Sep/2025
Quidel USD 1.45B 80.6M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Standard Biotools USD 472.44M 33.6M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.99B 69.86M Dec/2025